IT – INET Nordic – Reminder: Reference Data handling

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
IT – INET Nordic – Reminder: Reference Data handling for order book “Symbol” field (7/16)

As previously communicated In IT Notices (70/15) and ( 72/15 ), Nasdaq Nordic plans to utilize the ability of GCF to have the symbol field longer than 16 characters (up to 32 characters).

The change applies only to Exchange Traded Products and will be used when the issuer requires a longer symbol. As an effect, the symbols relayed over ITCH (Order Book Directory - Symbol) and GCF/TIP (BasicDataTradable [BDt] - Symbol [SYm]) can have different values. Please note that the ITCH symbol will not necessarily be a truncated version of the GCF/TIP symbol.

This change is planned for Exchange Traded Products on Nasdaq Copenhagen, Helsinki and Stockholm. Issuers of Warrants, Certificates and Exchange Traded Notes may opt to provide a longer symbol in addition to the current symbol. Where both values have been provided by the issuer, the longer symbol will be disseminated within GCF/TIP as Symbol [SYm]. Where no value has been provided for the longer symbol, standard symbol will be disseminated via GCF. As per current setup, ITCH will continue to disseminate the standard symbol within the “Symbol” field. This new handling of the order book “Symbol” is planned for GCF production as of February 1, 2016 and has been available to test in INET OTF and GCF- EXT2 and EXT4 as of December 14, 2015. For the list of test instruments with longer symbol applied, please contact operator@nasdaq.com .

Details

Issuers

An additional symbol field will be made available for issuer input. This additional symbol will be optional, will contain a maximum of 32 characters and must be unique. The current “Symbol” field continues as a required field and must also be unique.

Market participants and data feed customers

Customers taking GCF/TIP-feed or reference data file from File Delivery Service (FDS) will see the longer entry in applicable cases (i.e. when longer symbol is provided by the issuer) within the “Symbol” field. Symbol already today has 32 characters. ITCH customers will continue to see the current symbol with maximum length of 16 characters.

INET identifiers:

Market segments impacted:

Exchange / MIC Segment name Segment symbol Currency Seq. no GCF ID
XSTO OMX STO Warrants SEEQ WAR SEK 4 21
XSTO OMX STO Certificates SEEQ CERT SEK 160 256
XSTO OMX STO Exchange Traded Notes SEEQ COM SEK 158 264
XHEL OMX HEL Covered Warrants FIEQ WAR EUR 64 93
XHEL OMX HEL Certificates FIEQ CERT EUR 159 258
XHEL OMX HEL Exchange Traded Notes FIEQ COM EUR 157 456
XCSE OMX CPH Warrants DKWA WAR DKK 167 308
XCSE OMX CPH Certificates DKWA CERT DKK 168 310
XCSE OMX CPH Exchange Traded Notes DKEQ COM DKK 357 458

GCF/TIP and ITCH:

S ymbols relayed over GCF/TIP (BasicDataTradable [BDt] - Symbol [SYm]) and ITCH (Order Book Directory - Symbol) can have different values. Please note that the ITCH symbol will not necessarily be a truncated version of the GCF/TIP symbol.

Instruments where the Symbol field can differ between ITCH and GCF have the below instrument type:

ITCH message = Order Book Directory, Field = Financial Product, Value = 8 = Warrant

GCF/TIP messages = Basic Data Derivative [BDDe], field = DerivativeType [Dty] 4 = Warrant

The recommended mapping is to match:

ITCH GCF/TIP
Table Field Table Field
Order Book Directory Order Book Basic Data Tradable [BDt] SourceId [Si]

Protocol specifications

No protocol changes. No new field added in GCF/TIP for the longer symbol. Existing field “Symbol” will carry entries for the longer symbol in GCF/TIP, where this reference data has been provided by the issuer. “Symbol” field in GCF already today supports 32 characters.

Current versions of INET protocol specifications are available at the Nasdaq Nordic Technical Information website, under INET Nordic Protocol Specifications .

Implementation schedule

Time schedule

The order book Symbol handling change is planned for launch:

  • INET Test (OTF), GCF EXT2, GCF EXT4 – available as of December 14, 2015
  • GCF Production – February 1, 2016

Documentation

INET Nordic Market Model:

No updates in Market Model resulting from this change. The current version of the Market Model can be viewed at www.nasdaqomx.com/nordicrules .

Support

For technical questions, please contact Nasdaq Cash Equity Operations: Tel: +46 8 405 6410, E-mail: operator@nasdaq.com

A list of current test instruments can be obtained by contacting operator@nasdaq.com . Best regards, Nasdaq Nordic “Nasdaq Nordic” is not a legal entity but represents the common offering by Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd, Nasdaq Iceland hf. and Nasdaq Stockholm AB.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 454

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 59

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 283

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 493

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 66

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 77

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Ventas to Showcase Investment Strategy at Real Estate Conference

Updated Category News Views 44

Ventas Engages Investors at Upcoming Conference Ventas, Inc. (NYSE: VTR) is gearing up to take part in significant investor meetings at the BofA Securities 2024 Global Real Estate Conference. This event presents a valuable chance for the company to connect with investors and share insights about its strategic direction and business model. Event Details and Participation...

Continue Reading
BioLineRx Explores Synergy in Ovarian Cancer Treatment

Updated Category News Views 151

New Hope on the Ovarian Cancer Front Every so often, something comes along and makes you stop and think—could this be the game-changer in the making? Well, what BioLineRx Ltd. (NASDAQ: BLRX) and Hemispherian AS just dropped at the ESMO 2026 feels a bit like that silver lining for folks fighting the uphill battle against homologous recombination (HR)-proficient ovarian...

Continue Reading
Analyst Ratings Show Confidence in Datadog and Others

Updated Category News Views 80

Recent Upgrades by Top Analysts Leading financial analysts from Wall Street have adjusted their outlooks on several prominent companies, reflecting a more optimistic market sentiment. Upgrades often signify increased confidence in a company's performance and present potential investment opportunities for savvy investors. Here, we delve into some of the standout upgrades...

Continue Reading
Unpacking the Increased Short Interest in Ventas (NYSE: VTR)

Updated Category News Views 77

Understanding Ventas's Short Interest Surge Ventas recently recorded an uptick in its short percent of float, which now stands at 25.59% since the last report. This notable development means that 9.80 million shares are currently sold short, translating to 3.19% of all regular shares available for trading. Given the trading volume, it would take traders approximately 3.33...

Continue Reading
Precigen's PAPZIMEOS: 7-Year Exclusivity & Long-Term Success

Updated Category News Views 54

Precigen's Game-Changer: PAPZIMEOS Secures Seven-Year Exclusivity Here's how you carve out a solid niche in the biotech world: deliver some killer results and snag yourself seven years in the driver’s seat. That's exactly what Precigen (NASDAQ: PGEN) has done with their PAPZIMEOS therapy, which got the stamp of approval from the FDA as the first exclusive treatment for...

Continue Reading